Drug industry antitrust act : hearings before the Antitrust Subcommittee (Subcommittee No. 5) of the Committee on the Judiciary, House of Representatives, Eighty-seventh Congress, second session, on H.R. 6245, a bill to amend and supplement the antitrust laws with respect to the manufacture and distribution of drugs and for other purposes, May 17, 18, 23, and 24, 1962.
Author/creator | United States. Congress. House. Committee on the Judiciary. Subcommittee No. 5. |
Format | Book and Print |
Publication Info | Washington : U.S. Govt. Print. Off, 1962. |
Description | vii, 908 pages : illustrations ; 24 cm |
Subject(s) |
Click here for more information about this title
Abstract | Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs. |
General note | Emanuel Celler, subcommittee chairman. |
Other forms | Available also in microform in CIS US congressional committee hearings, accession number (87)H1952-1. |
LCCN | 62062353 |
Govt. docs number | Y 4.J 89/1:87/32 |
Available Items
Library | Location | Call Number | Status | Item Actions | |
Joyner | Fed Docs Stacks | Y 4.J 89/1:87/32 | ✔ Available | Place Hold |